Researchers found the therapy downregulated VEGF expression and improved retinal thickness in neovascular age-related macular degeneration patients.

The Italian Group of Vitreoretinal Surgery (Givre) announces a new appointment with AlfaLab: experts in discussion. It is ...

Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biotechnology company developing gene therapies for the treatment of ...

Four children aged 1.0 to 2.8 years with confirmed AIPL1 mutations received a subretinal injection of rAAV8.hRKp.AIPL1 in one ...

Anti-VEGF drugs provide anatomical control over exudation, effectively reducing subretinal and intraretinal fluid. Administered through intravitreal injection, anti-VEGF drugs need to be ...

Patients with neovascular age-related macular degeneration (nAMD) experienced improvements in central macular thickness and ...

Background To investigate the short-term outcomes of treatment with intravitreal aflibercept in cases with wet age-related macular degeneration (AMD) resistant to ranibizumab. Methods The study ...